[clinicaltrials_resource:29461117b3859c326166fc28d676d8ae]
clinicaltrials:NCT00258284clinicaltrials:NCT00499694Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors [clinicaltrials:NCT00914147]clinicaltrials:NCT01051570clinicaltrials:NCT01205646clinicaltrials:NCT01468532clinicaltrials:NCT01656304Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer [clinicaltrials:NCT01812668]clinicaltrials:NCT02058706
responsible party [clinicaltrials_vocabulary:responsible-party]
[clinicaltrials_resource:29461117b3859c326166fc28d676d8ae]
Bio2RDF identifier
29461117b3859c326166fc28d676d8ae
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:29461117b3859c326166fc28d676d8ae
investigator affiliation [clinicaltrials_vocabulary:investigator-affiliation]
Barbara Ann Karmanos Cancer Institute
investigator full name [clinicaltrials_vocabulary:investigator-full-name]
Ulka Vaishampayan
investigator title [clinicaltrials_vocabulary:investigator-title]
Principal Investigator
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:29461117b3859c326166fc28d676d8ae
type
label
[clinicaltrials_resource:29461117b3859c326166fc28d676d8ae]
@en